人口
免疫分型
表型
医学
谱系(遗传)
抗原
免疫学
生物
遗传学
基因
环境卫生
作者
Irina Demina,Ekaterina Mikhailova,Elena Zerkalenkova,Alexandra Semchenkova,Julia Roumiantseva,Alexandra Borkovskaya,Evgeny Matveev,Д. С. Абрамов,Д. М. Коновалов,Natalia Miakova,Natalia Ponomareva,Julia Belkina,Konstantin Kondratchik,Yulia Olshanskaya,Galina Novichkova,Alexander Karachunskiy,А. М. Попов
出处
期刊:American Journal of Clinical Pathology
[Oxford University Press]
日期:2024-03-21
摘要
Abstract Objectives Mixed-phenotype acute leukemia (MPAL) is a rare disease associated with difficulties in the correct lineage assignment of leukemic cells. One of the least common subtypes within this category is characterized by the simultaneous presence of B- and T-lineage–defining antigens. Each case of suspected B/T MPAL should be considered in light of all available laboratory and clinical data to avoid misdiagnosis. Methods In this study, we describe 6 pediatric patients who presented with leukemic blasts bearing B- and T-lineage antigens at diagnosis, including their clinical, immunophenotypic, morphologic, and cytogenetic characteristics. Results In 3 patients, more or less distinct populations of B- and T-lymphoid origin were found; the other 3 patients had a single mixed-phenotype blast population. All cases fulfilled the World Health Organization criteria, but not all of them turned out to be bona fide cases of B/T MPAL according to the available clinical and laboratory data. Found genetic lesions were helpful for the confirmation of MPAL instead of 2 concomitant tumors, but for a general B/T MPAL diagnosis, genetic studies provided the only descriptive data. Conclusions The accurate diagnosis of B/T MPAL requires a multidisciplinary approach combining high-tech laboratory methods and close cooperation between treating physicians and pathologists.
科研通智能强力驱动
Strongly Powered by AbleSci AI